Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
terminated267%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Trigger Time in Advanced Maternal Age Patients With Low AMH

NCT03740880
completedphase_3

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

NCT04224818
terminatedphase_4

Study of Dual Trigger Ovulation in Oocyte Donors

NCT01443546

Clinical Trials (3)

Showing 3 of 3 trials
NCT03740880Not Applicable

Trigger Time in Advanced Maternal Age Patients With Low AMH

Terminated
NCT04224818Phase 3

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

Completed
NCT01443546Phase 4

Study of Dual Trigger Ovulation in Oocyte Donors

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3